China In Vitro Diagnostics (IVD) - Opportunity Assessment and Forecast 2021
©
China In Vitro Diagnostics (IVD) - Opportunity Assessment and Forecast 2021
Research Beam added a report on “China In Vitro Diagnostics (IVD) - Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021”
Summary
The in-vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high-end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.
Long-term Outlook:
China IVD Market: Segment wise Outlook
Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.
China IVD Market: Companies wise Outlook
Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi-auto and automatic biochemistry analyzers to low and mid-end market users.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.
Read More Here: http://www.researchbeam.com/china-in-vitro-diagnostics-ivd-opportunity-assessment-competitive-landscape-and-forecasts-to-2021-market
Table Of Contents
1. Executive Summary
2. China In Vitro Diagnostics Market & Forecast (2010 - 2021)
3. China In Vitro Diagnostics Market Share & Forecast (2010 - 2021)
3.1 China In Vitro Diagnostics Market Share Outlook
4. China In Vitro Diagnostics Market - Segment Analysis (2010 - 2021)
4.1 China Clinical Chemistry Market & Forecast
5. China In Vitro Diagnostics Market - Company Wise Sales Analysis (2010 - 2021)
5.1 Roche Diagnostics - China IVD Sales & Forecast
6. China IVD - Regulation & its Latest Development
7. China IVD - Future Prospects in Attractive In Vitro Diagnostics Segments
8. China IVD - Regional Trends & Opportunities
9. China IVD - Main Participants/Contributors
10. China - Major IVD Product Companies Outlook
11. China - Major Private Clinical Labs & Diagnostic Services Companies Outlook
12. China In Vitro Diagnostics Market - Growth Drivers
13. China In Vitro Diagnostics Market – Challenges
Enquire At: http://www.researchbeam.com/china-in-vitro-diagnostics-ivd-opportunity-assessment-competitive-landscape-and-forecasts-to-2021-market/enquire-about-report
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/
Research Beam added a report on “China In Vitro Diagnostics (IVD) - Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021”
Summary
The in-vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high-end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.
Long-term Outlook:
China IVD Market: Segment wise Outlook
Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.
China IVD Market: Companies wise Outlook
Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi-auto and automatic biochemistry analyzers to low and mid-end market users.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.
Read More Here: http://www.researchbeam.com/china-in-vitro-diagnostics-ivd-opportunity-assessment-competitive-landscape-and-forecasts-to-2021-market
Table Of Contents
1. Executive Summary
2. China In Vitro Diagnostics Market & Forecast (2010 - 2021)
3. China In Vitro Diagnostics Market Share & Forecast (2010 - 2021)
3.1 China In Vitro Diagnostics Market Share Outlook
4. China In Vitro Diagnostics Market - Segment Analysis (2010 - 2021)
4.1 China Clinical Chemistry Market & Forecast
5. China In Vitro Diagnostics Market - Company Wise Sales Analysis (2010 - 2021)
5.1 Roche Diagnostics - China IVD Sales & Forecast
6. China IVD - Regulation & its Latest Development
7. China IVD - Future Prospects in Attractive In Vitro Diagnostics Segments
8. China IVD - Regional Trends & Opportunities
9. China IVD - Main Participants/Contributors
10. China - Major IVD Product Companies Outlook
11. China - Major Private Clinical Labs & Diagnostic Services Companies Outlook
12. China In Vitro Diagnostics Market - Growth Drivers
13. China In Vitro Diagnostics Market – Challenges
Enquire At: http://www.researchbeam.com/china-in-vitro-diagnostics-ivd-opportunity-assessment-competitive-landscape-and-forecasts-to-2021-market/enquire-about-report
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/